 |
GugulipidGugulipid is a registered trademark of Sabinsa Corporation and used to reduce the levels of harmful serum lipids in the bloodstream. The compound is an extract prepared from the oleogum resin (gum resin) of Commiphora mukul, an Indian medicinal tree. In several clinical trials in India it has been suggested that a small decrease in bad (LDL) levels of cholesterol does take place with the compound. In addition, studies in mice found that gugulipid may have anti-diabetic properties. All in all, much more research is needed on this compound before anything definite, particularly in terms of effectiveness in cholesterol management, can be said. Gugulipid - StudiesGuggul (Commiphora mukul) potentially ameliorates hypothyroidism in female mice. Phytother Res. 2005 Jan;19(1):78-80. Guggul and Prescription Drugs. The Journal of Pharmacology and Experimental Therapeutics, August 2004. Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA. 2003 Aug 13;290(6):765-72. The effectiveness of Commiphora mukul (guggul) for osteoarthritis of the knee: an outcomes study. Singh BB,. Southern California University of Health Sciences, USA. Altern Ther Health Med. 2003 May-Jun;9(3):74-9. The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL. Atherosclerosis. 2004 Feb;172(2):239-46.
|